Finance

Lists
002900:SHE
Harbin Medisan Pharmaceutical Co Ltd
CNÂ¥12.97
-0.08%
(-0.0100) 1D
Sep 30, 3:04:48 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002900...
Open
CNÂ¥13.05
High
CNÂ¥13.27
Low
CNÂ¥12.80
Mkt. cap
4.10B
Avg. vol.
21.01M
Volume
24.25M
52-wk high
CNÂ¥17.19
52-wk low
CNÂ¥8.93
EPS
-CNÂ¥0.92
Shares outstanding
316.35M
No. of employees
2K
Open
CNÂ¥13.05
High
CNÂ¥13.27
Low
CNÂ¥12.80
Mkt. cap
4.10B
Avg. vol.
21.01M
Volume
24.25M
52-wk high
CNÂ¥17.19
52-wk low
CNÂ¥8.93
EPS
-CNÂ¥0.92
Shares outstanding
316.35M
No. of employees
2K
News stories
From web sources and news partners
About Harbin Medisan Pharmaceutical Co Ltd
CEO-
Employees2.09K
FoundedJun 21, 1996
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
167.53M
208.77M
228.84M
199.96M
Cost of goods sold
88.90M
193.55M
135.29M
123.65M
Cost of revenue
88.90M
193.55M
135.29M
123.65M
Research and development expenses
25.86M
29.72M
13.62M
14.79M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
124.53M
137.94M
101.78M
90.02M
Operating expense
142.44M
177.23M
119.96M
107.11M
Total operating expenses
231.34M
370.78M
255.25M
230.76M
Operating income
-63.81M
-162.01M
-26.41M
-30.80M
Other non operating income
471.56K
516.40K
399.85K
1.49M
EBT including unusual items
-121.36M
-127.18M
-6.89M
-42.24M
EBT excluding unusual items
-63.30M
-162.23M
-24.15M
-31.47M
Income tax expense
-4.16M
2.91M
846.69K
-4.65M
Effective tax rate
3.43%
-2.29%
-12.29%
11.01%
Other operating expenses
-6.57M
10.43M
3.33M
2.36M
Net income
-116.45M
-130.78M
-7.06M
-37.14M
Net profit margin
-69.51%
-62.64%
-3.08%
-18.57%
Earnings per share
-
-
-
-
Interest and investment income
6.36M
5.97M
9.31M
4.95M
Interest expense
-5.98M
-6.96M
-7.44M
-6.99M
Net interest expenses
385.33K
-990.84K
1.86M
-2.04M
Depreciation and amortization charges
-
-
-
-
EBITDA
-38.68M
-128.83M
6.77M
3.78M
Gain or loss from assets sale
-48.14K
520.67K
-
500.78K
AI content may include mistakes. Learn more
Google apps